Kytopen
Pre-clinicalKytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing problems at discovery
Founded
2017
Focus
Cell & Gene Therapy
About
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing problems at discovery
Funding History
3Total raised: $23.5M
Series B$12MNorthpond VenturesJan 15, 2022
Series A$8MNorthpond VenturesJun 15, 2020
Seed$3.5MThe EngineJun 15, 2018
Company Info
TypePrivate
Founded2017
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile